Houghton M (November 2009). „The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatologysvezak 51 (broj 5): str. 939.–948.. DOI:10.1016/j.jhep.2009.08.004. PMID19781804.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). „Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Diseasesvezak 39 (broj 1): str. 2.–17.. DOI:10.1016/j.dld.2006.06.008. PMID16884964.
Iannuzzella, F; Vaglio, A; Garini, G (May 2010). „Management of hepatitis C virus-related mixed cryoglobulinemia”. Am. J. Med.svezak 123 (broj 5): str. 400.–408.. DOI:10.1016/j.amjmed.2009.09.038. PMID20399313.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (December 2011). „An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int.. DOI:10.1111/j.1478-3231.2011.02684.x. PMID22142261.
Xia, X; Luo, J, Bai, J, Yu, R (2008). „Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public healthsvezak 122 (broj 10): str. 990.–1003.. DOI:10.1016/j.puhe.2008.01.014. PMID18486955.
Tohme RA, Holmberg SD (June 2010). „Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatologysvezak 52 (broj 4): str. 1497.–1505.. DOI:10.1002/hep.23808. PMID20635398.
Lock G, Dirscherl M, Obermeier F, et al. (September 2006). „Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat.svezak 13 (broj 9): str. 571.–573.. DOI:10.1111/j.1365-2893.2006.00735.x. PMID16907842.
Halliday, J; Klenerman, P, Barnes, E (2011). „Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccinessvezak 10 (broj 5): str. 65.–72.. DOI:10.1586/erv.11.55. PMID21604986.
Torresi, J; Johnson, D, Wedemeyer, H (2011). „Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatologysvezak 54 (broj 6): str. 1273.–1285.. DOI:10.1016/j.jhep.2010.09.040. PMID21236312.
Foote BS, Spooner LM, Belliveau PP (September 2011). „Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacothersvezak 45 (broj 9): str. 1085.–93.. DOI:10.1345/aph.1P744. PMID21828346.
Smith LS, Nelson M, Naik S, Woten J (May 2011). „Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacothersvezak 45 (broj 5): str. 63.9–48.. DOI:10.1345/aph.1P430. PMID21558488.
Alavian SM, Tabatabaei SV (April 2010). „Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat.svezak 17 (broj 4): str. 236.–244.. DOI:10.1111/j.1365-2893.2009.01170.x. PMID19638104.
Fung J, Lai CL, Hung I, et al. (September 2008). „Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseasessvezak 198 (broj 6): str. 808.–812.. DOI:10.1086/591252. PMID18657036.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). „Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Sciencesvezak 244 (broj 4902): str. 359.–362.. DOI:10.1126/science.2523562. PMID2523562.
Kuo G, Choo QL, Alter HJ, et al. (April 1989). „An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Sciencesvezak 244 (broj 4902): str. 362.–364.. DOI:10.1126/science.2496467. PMID2496467.
El Khoury, A. C.; Klimack, W. K., Wallace, C., Razavi, H. (2011-12-01). „Economic burden of hepatitis C-associated diseases in the United States”. Journal of Viral Hepatitis. DOI:10.1111/j.1365-2893.2011.01563.x.
Ahn, J; Flamm, SL (2011). „Hepatitis C therapy: other players in the game”. Clinics in liver diseasesvezak 15 (broj 3): str. 641.–656.. DOI:10.1016/j.cld.2011.05.008. PMID21867942.
Boyer, JL (2001.). Liver cirrhosis and its development: proceedings of the Falk Symposium 115. Springer. str. 344. ISBN9780792387602.
Zuckerman, edited by Howard Thomas, Stanley Lemon, Arie (2008.). Viral Hepatitis. (3rd ed. izd.). Oxford: John Wiley & Sons. str. 532. ISBN9781405143882.
Houghton M (November 2009). „The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatologysvezak 51 (broj 5): str. 939.–948.. DOI:10.1016/j.jhep.2009.08.004. PMID19781804.
Mueller, S; Millonig, G, Seitz, HK (2009-07-28). „Alcoholic liver disease and hepatitis C: a frequently underestimated combination.”. World journal of gastroenterology : WJGsvezak 15 (broj 28): str. 3462.–3471.. PMID19630099.
Alter, MJ (2007-05-07). „Epidemiology of hepatitis C virus infection.”. World journal of gastroenterology : WJGsvezak 13 (broj 17): str. 2436.–2441.. PMID17552026.
Ozaras, R; Tahan, V (2009). „Acute hepatitis C: prevention and treatment.”. Expert review of anti-infective therapysvezak 7 (broj 3): str. 351.–361.. PMID19344247.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). „Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Diseasesvezak 39 (broj 1): str. 2.–17.. DOI:10.1016/j.dld.2006.06.008. PMID16884964.
Louie, KS; Micallef, JM, Pimenta, JM, Forssen, UM (2011). „Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.”. Journal of viral hepatitissvezak 18 (broj 1): str. 1.–7.. PMID20796208.
Iannuzzella, F; Vaglio, A; Garini, G (May 2010). „Management of hepatitis C virus-related mixed cryoglobulinemia”. Am. J. Med.svezak 123 (broj 5): str. 400.–408.. DOI:10.1016/j.amjmed.2009.09.038. PMID20399313.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (December 2011). „An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int.. DOI:10.1111/j.1478-3231.2011.02684.x. PMID22142261.
Maheshwari, A; Thuluvath, PJ (2010). „Management of acute hepatitis C.”. Clinics in liver diseasesvezak 14 (broj 1): str. 169.–176.; x. PMID20123448.
Pondé, RA; Mikhaĭlova, A (2011). „Hidden hazards of HCV transmission.”. Medical microbiology and immunologysvezak 200 (broj 1): str. 7.–11.. PMID20461405.
Xia, X; Luo, J, Bai, J, Yu, R (2008). „Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public healthsvezak 122 (broj 10): str. 990.–1003.. DOI:10.1016/j.puhe.2008.01.014. PMID18486955.
Imperial, JC (2010). „Chronic hepatitis C in the state prison system: insights into the problems and possible solutions.”. Expert review of gastroenterology & hepatologysvezak 4 (broj 3): str. 355.–364.. PMID20528122.
Vescio, MF; Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R (2008). „Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.”. Journal of epidemiology and community healthsvezak 62 (broj 4): str. 305.–313.. PMID18339822.
Tohme RA, Holmberg SD (June 2010). „Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatologysvezak 52 (broj 4): str. 1497.–1505.. DOI:10.1002/hep.23808. PMID20635398.
Lock G, Dirscherl M, Obermeier F, et al. (September 2006). „Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat.svezak 13 (broj 9): str. 571.–573.. DOI:10.1111/j.1365-2893.2006.00735.x. PMID16907842.
Lam, NC; Gotsch, PB, Langan, RC (2010-11-15). „Caring for pregnant women and newborns with hepatitis B or C.”. American family physiciansvezak 82 (broj 10): str. 1225.–1229. PMID21121533.
Mast EE (2004). „Mother-to-infant hepatitis C virus transmission and breastfeeding”. Advances in Experimental Medicine and Biologysvezak 554: str. 211.–216.. PMID15384578.
Senadhi, V (2011). „A paradigm shift in the outpatient approach to liver function tests.”. Southern medical journalsvezak 104 (broj 7): str. 521.–525.. PMID21886053.
Halliday, J; Klenerman, P, Barnes, E (2011). „Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccinessvezak 10 (broj 5): str. 65.–72.. DOI:10.1586/erv.11.55. PMID21604986.
Hagan, H; Pouget, ER, Des Jarlais, DC (2011-07-01). „A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.”. The Journal of infectious diseasessvezak 204 (broj 1): str. 74.–83.. PMID21628661.
Torresi, J; Johnson, D, Wedemeyer, H (2011). „Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatologysvezak 54 (broj 6): str. 1273.–1285.. DOI:10.1016/j.jhep.2010.09.040. PMID21236312.
Ilyas, JA; Vierling, JM (2011). „An overview of emerging therapies for the treatment of chronic hepatitis C.”. Clinics in liver diseasesvezak 15 (broj 3): str. 515.–536.. PMID21867934.
Foote BS, Spooner LM, Belliveau PP (September 2011). „Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacothersvezak 45 (broj 9): str. 1085.–93.. DOI:10.1345/aph.1P744. PMID21828346.
Smith LS, Nelson M, Naik S, Woten J (May 2011). „Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacothersvezak 45 (broj 5): str. 63.9–48.. DOI:10.1345/aph.1P430. PMID21558488.
Alavian SM, Tabatabaei SV (April 2010). „Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat.svezak 17 (broj 4): str. 236.–244.. DOI:10.1111/j.1365-2893.2009.01170.x. PMID19638104.
Liu, J; Manheimer, E, Tsutani, K, Gluud, C (2003). „Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.”. The American journal of gastroenterologysvezak 98 (broj 3): str. 538.–544.. PMID12650784.
Rambaldi, A; Jacobs, BP, Gluud, C (2007-09-17). „Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.”. Cochrane database of systematic reviews (Online) (broj 4): str. CD003620. PMID17943794.
Fung J, Lai CL, Hung I, et al. (September 2008). „Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseasessvezak 198 (broj 6): str. 808.–812.. DOI:10.1086/591252. PMID18657036.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). „Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Sciencesvezak 244 (broj 4902): str. 359.–362.. DOI:10.1126/science.2523562. PMID2523562.
Kuo G, Choo QL, Alter HJ, et al. (April 1989). „An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Sciencesvezak 244 (broj 4902): str. 362.–364.. DOI:10.1126/science.2496467. PMID2496467.
Eurosurveillance editorial, team (2011-07-28). „World Hepatitis Day 2011.”. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletinsvezak 16 (broj 30). PMID21813077.
Wong, JB (2006). „Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.”. PharmacoEconomicssvezak 24 (broj 7): 661–672. PMID16802842.
Ahn, J; Flamm, SL (2011). „Hepatitis C therapy: other players in the game”. Clinics in liver diseasesvezak 15 (broj 3): str. 641.–656.. DOI:10.1016/j.cld.2011.05.008. PMID21867942.
Vermehren, J; Sarrazin, C (2011). „New HCV therapies on the horizon.”. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseasessvezak 17 (broj 2): str. 122–134. PMID21087349.
